+ All Categories
Home > Documents > Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification...

Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification...

Date post: 23-Dec-2015
Category:
Upload: delilah-whitehead
View: 247 times
Download: 0 times
Share this document with a friend
Popular Tags:
68
Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Transcript
Page 1: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Species of plasmodium.

Clinical features and complications.

Life-cycle of plasmodium.

Classification of antimalarial drugs.

Individual drugs.

Page 2: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Each year, it causes disease in approximately 650 million people and kills between one and three million.

Page 3: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Plasmodium falciparum.

P.vivax P.vivax & P.ovale.

P.ovale is mainly confined to Africa.

Page 4: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Page 5: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Acute falicparum malaria is potentially fatal.

Symptoms of malaria.

Page 6: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Complications:-.

Chronic repeated infection.

Page 7: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Page 8: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• One cycle of liver invasion and multiplication:

• A) P vivaxB) P falciparumC) P. malariaeD) P ovale

Page 9: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Tissue schizontocides:-.

Page 10: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Blood schizontocides:-.

Page 11: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Gametocides:-destroy the sexual forms of the parasite.

Page 12: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Hypnozoitocides:-kill the dormant hypnozoites of P.vivax & P.ovale in the liver.

Page 13: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Sprontocides:-interupt development of sporogonic phase in mosquitoes .

Page 14: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Page 15: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Prophylactic:-to prevent clinical attack

1. Suppressive prophylaxis:-use of blood schizontocides to prevent acute attack

2. Causal prophylaxis:-use of tissue schizontocides to prevent the parasite from establishing in the liver

Page 16: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Curative:-suppressive treatment of the acute attack usually with blood schizontocides.

Prevention of transmission:- Erradication of infection in mosquitoes using gametocytocides or sprontocides.

Page 17: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Page 18: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Chloroquine and amodiaquine

potent blood schizontocide.

At the acid pH of the lysosome it is converted into protonated form, trapped in the parasite.

Inhibits digestion of haemoglobin by the parasite AA supply necessary for parasite viability.

It also haem polymerase.

Page 19: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Page 20: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Resistance results from enhanced efflux of the expression of the human multi drug resistance transpoter P-glycoprotein.

Page 21: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

It is a disease modifying antirheumatoid drug.

Rapidly & completely absorbed from the GIT, has high volume of distribution(100-1000l/kg).

Concentrated into parasitised RBCs.

Page 22: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Released slowly from tissues & metabolized in the liver, excreted in the urine 70% unchanged. Elimination is slow.

Initial t½ =2-3days & terminal t ½=1-2months.

ADR:-Nausea, vomiting, dizziness, blurring of vision, headache,urticarial symptoms.

Large doses retinopathy.

Bolus injection hypotension & dysrrhythmias

Safe for pregnant women.

Page 23: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• Plasmodial resistance to chloroquine is due to

(A) Change in receptor structure

(B) Increased expression of P-glycoprotein

(C) Increase in the activity of DNA repair mechanisms

(D) Induction of inactivating enzymes

(E) Inhibition of dihydrofolate reductase

Page 24: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• Of the following which is not a clinical use of chloroquine are:-

• A) amebiasisB) malaria prophylaxisC) acute malarial attacksD) guardiasis

• E) rheumatoid arthritis

Page 25: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Blood schizontocide effective against the erythrocytic form of all species of malaria.

Acts by parasite’s haem polymerase.

Depresses the myocardium,

Page 26: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Mild oxytoxic effect on pregnant uterus,

Slight neuromuscular blocking action,

weak antipyretic action.

Given orally in a7 day course or by slow IV for severe P. falciparum infection,

Metabolized in the liver,t½=10h.

Page 27: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

ADR:-bitter taste →poor compliance,

NV, concentrations >30-60mol/l cinchonism [nausea, dizziness, headache, tinnitus, blurring of vision].

Higher doses can cause hypotension , cardiac arrhythmias, ,delirium, coma.

Page 28: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Hypoglycaemia, blood dyscrasias, hypersensitivity reactions

Blackwater fever, a fatal condition in which acute haemolytic anaemia is associated with renal failure.

Resistance →↑ expression of P-glycoprotein.

Page 29: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

CONTRAINDICATIONS

Prolonged QT Interval

Glucose-6-Phosphate Dehydrogenase Deficiency

Myasthenia Gravis

Hypersensitivity

Optic Neuritis, auditory problems

Dose should be reduced in renal insufficiency

Page 30: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Drug Interactions:-

Antacids: Antacids containing aluminum and/or magnesium may delay or decrease absorption of quinine.

Erythromycin (CYP3A4 inhibitor):

Cimetidine

Mefloquine.

Quinine can raise plasma levels of warfarin and digoxin.

Page 31: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• Which is false about quinine :

A) rapid onsetB) poorly effective blood schizonticide against P vivaxC) gametocidal for P ovale

D) causes cinchonism E) causes hypoglycemia

Page 32: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Atovaquone parasite’s electron transport chain by mimicking the natural substrate ubiquinone

Has synergestic effect with proguanil.

Page 33: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Pregnant & breast feeding women should not use atavaquone.

Resistance to atavaquone is rapid , results from a single point mutation in the gene for cytochrome b.

Low bioavailability, slow, erratic absorption, ↑by food, highly protein- bound, t½ =2-3d, eliminated unchanged in faeces.

ADR:- fever, rash, NVD, insomnia

Page 34: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Blood schizontocide active against Pvivax & P.falciparum, but no effect on hepatic form of the parasite.

Inhibits haem polymerase.

Resistance has occurred in southeast Asia.

Page 35: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Given orally ,well absorbed, slow onset of action, t½=30d enterohepatic recycling or tissue storage.

ADR:-GIT disturbances, transient CNS toxicity, confusion, Gidiness, dysphoria, insomnia.

May provoke neuropsychiatric disorder.

Contra-indicated in pregnant women.

Page 36: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• Mefloquine : • A) active against P

falciparum gametocytesB) indicated to pregnant womenC) active against hepatic stages of P vivax

D) contraindicated in cardiac conduction anomalies

Page 37: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Blood schizontocide, active against strains resistant to chloroquine , pyrimethamine, quinine.Cross resistance in falicparum infection occurred .Absorbed orally slowly , t½=11-12d., Absorption by a fatty meal, elimination in faeces.

Page 38: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

ADR:-abdominal pain, headache, transient in hepatic enzymes, cough, pruritus, lengthening of Q-T interval.

May cause haemolytic anaemia & convulsions.

Reserved for infection caused by resistant organisms.

Contraindicated with mefloquine.

Patients with cardiac conduction defects.

In pregnancy → embriotoxic in animals

Page 39: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Type 1 antifolates sulphonamides & sulphones , competes with PABA.

Type 2 ,pyrimethamine & proguanil dihydrofolate reductase.

Page 40: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Have slow action against the erythrocytic forms of the parasite.

Pyrimethamine is used in combination with either dapsone or sulfadoxine.

Page 41: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Sulfonamides & sulfones are active against the erythrocytic forms of P.falciparum.Pyrimethamine -sulfodoxine is used for chloroquine –resistant malaria.Pyrimethamine & proguanil are absorbed orally slowly.t½ of pyrimethamine =4d, proguanil=16h.Proguanil is metabolized to an active metabolite ,cycloguanil which is excreted in urine.

Page 42: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

ADR:- large doses of pyrimethamine -dapsone combination causes haemolytic anaemia, agranulocytosis.In high doses pyrimethamine mammalian dihydrofolate reductase megaloblastic anaemia.Resistance → a single mutation in the genes encoding parasite dihydrofolate reductase.

Page 43: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• Antimalarials dihydrofolate reductase inhibitors:-

• A) chloroquine

• B) chloroguanideC) pyrimethamine

• D) trimethoprim E) primaquine

Page 44: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• Concerning sulfonamides & sulfones and antimalarial activity: -

a) Blood schizonticidal activity against P falciparum

b) useful in acute sever attack of P falciparum

c)  Active against liver stages of P falciparum or P vivax

d) rapid onset of action

e)  minimal side effects

Page 45: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Active against liver hypnozoites, produces radical cure for parasites which have dormant stage in the liver [P.ovale &P.vivax].Has gametocytcide action , most effective for preventing transmission of the disease.Combined with chloroquine, mechanism unknown, resistance rare.

Page 46: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Given orally, rapidly metabolized to etaquine & tafenoquine which are more active & slowly metabolized, t½=3-6hFor radical cure of acute vivax and oval malaria”:- chloroquine is given to eradicate erythrocytic forms and then primaquine(30mg daily for 14 days) to eradicate liver hypnozoites

Page 47: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

ADR:- GIT disturbances, in large doses methaemoglobinaemia with cyanosis

Causes haemolysis in G-6-P –dehdrogenase deficiency, metabolites have greater haemolytic activity

Page 48: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• This is the antimalarial agent most commonly associated with causing an acute hemolytic reaction in patients with glucose-6-phosphate dehydrogenase deficiency.

• (A) Chloroquine • (B) Clindamycin• (C) Mefloqui • (D) Primaquine• (E) Quinine

Page 49: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Derived from the herb qing haosu [Artemisia].

Artemisinin is poorly soluble in water & fast acting blood schizontocide.

Effective in treating acute attack , including chloroquine –resistant & cerebral malaria.

Artemesia annua

Page 50: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Artesunate[a water- soluble derivative], artemether & artether[synthetic analogues] have higher activity & are better absorbed.

It damages the parasite membrane by carbon- centered free radicals.

Rapidly absorbed , widely distributed,

Page 51: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Converted in the liver to the active metabolite dihydroartemisinin.

t½ of artemisinin 4h,artesunate=45min, artemether 4-11h.

ADR:- transient heart block, neutrophil count, brief episodes of fever.

Neurotoxic in animal , no reported resistance

Page 52: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?

• An antimalarial drug effective against multidrug resistant P. falciparum, which rapidly terminates an attack of malarial fever, but has a short duration of action, so that recrudescence is common:-

• (A) Chloroquine • (B) Artemisinine• (C) Mefloquine • (D) Primaquine• (E) Quinine

Page 53: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Doxycycline is used as a suppressive prophylactic in areas where mefloquine resistance is common.

Clindamycin has proved effective in the treatment of uncomplicated falicparum malaria, may be used in combination with quinine.

Page 54: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Use of prophylactic drugs is seldom practical for full-time residents of malaria-endemic areas, and their use is usually restricted to short-term visitors and travelers to malarial regions. People temporarily visiting malaria-endemic areas usually begin taking the drugs one to two weeks before arriving and must continue taking them for 4 weeks after leaving.

Page 55: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

include mefloquine ,doxycycline and the combination of atovaquone and proguanil hydrochloride

Page 56: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

A 35-year-old medical entomologist comes to the hospital with chief complaints of fever, headache, and photophobia. This illness began about 6 days prior to admission, when he returned from a 2-month visit to the jungles of Central and South America. He took a drug for prophylaxis of malaria before starting the trip. On his return flight, about 6 days prior to admission, he described having fever and shaking chills. He saw his physician 2 days prior to admission; the physician made a diagnosis of influenza and

prescribed tetracycline .

Page 57: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

On the day of admission, the patient had shaking chills followed by temperature elevation to 104°F (40°C). Physical examination revealed a well-developed man who appeared ill. There is some left upper quadrant tenderness but no organomegaly; blood pressure,126/90; pulse, 120; and respirations, 22. Laboratory findings were hemoglobin, 14.5 mg/dL (normal, 13.4–17.4 mg/dL); hematocrit, 45% (normal, 40–54%); Giemsa-stained blood smear (thick and thin) revealed Plasmodium vivax

Page 58: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Q1

• The drug she took for prophylaxis was probably (A) Chloroquine (B) Mefloquine (C) Primaquine (D) Proguanil (E) Pyrimethamine

Page 59: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Q2?

• Which of the following drugs should be used for oral treatment of the entomologist's acute attack of P vivax malaria?

• (A) Chloroquin • (B) Mefloquine • (C) Primaquin • (D) Pyrimethamine-sulfadoxine

• (E) Quinine

Page 60: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Q3?

• Which of the following drugs should be given later in order to eradicate schizonts and latent hypnozoites in the patient's liver?

(A) Chloroquine

(B) Mefloquine

(C) Primaquine

(D) Proguanil

(E) Quinine

Page 61: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

About 90% of malaria deaths occur in sub Saharan Africa.The key factor contributing tomalarial morbidity & mortality is resistance of P.falciparum to chloroquine, sulfodoxin-pyrimethamin [SP] & amodiaquine.Artemisinin compounds produce a very rapid therapeutic response ,active against multi-drug resistant P.falciparum, well tolerated by the patient,gametocyte carriage, no resistance is detected.Artemisinins cure falciparum malaria in 7d, if combined with another drug in 3d.

Page 62: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

WHO recommends that all countries experiencing resistance to conventional monotherapies should use combination therapy, preferably containing artemisinins [ACTs -artemisinin-based combination therapies].WHO recommends the following therapeutic options:-

1. Artemether/lumefantrine2. Artesunate+amodiaquine3. Artesunate+SP4. Artesunate+ mefloquine [area with low to

moderate transmission.5. Amodiaquine+SP

Page 63: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Page 64: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.
Page 65: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Quiz?• Regarding drugs used for malaria, which

one of the following statements is false?

(A) Chloroquine is the drug of choice for acute attacks of non falciparum malaria

(B) Cinchonism is associated with the use of quinine

(C) Hemolysis has occurred with primaquine in patients deficient in G6P dehydrogenase

(D) Mefloquine is used for prophylaxis in regions where chloroquine resistance occurs

(E) Quinine is contraindicated in pregnancy

Page 66: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

A57-year-old photographer developed fever, diarrhea, headache, vomiting, and dark urine about 10 days after returning to the United States from a month-long trip to East Africa. The patient has been taking chloroquine and proguanil chemoprophylaxis. On physical examination the patient is feverish, agitated, sweating, weak, and in mild distress, with a blood pressure 95/60 (normal, 120/80), a pulse of 120 (normal, 60–100),

Page 67: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

and temperature of 104°F (40°C) (normal, 98.6°F, 37°C). Laboratory findings are a hematocrit of 25% (normal for male, 40–54%); platelet count 29,000 (normal, 150,000–400,000/mm3); parasitemia 6% (P. falciparum); serum creatinine 3.5 mg/dL (Normal for male, 0.8–1.5 mg/dL); and plasma glucose 39 mg/dL(Normal fasting, 65–110 mg/dL).

Page 68: Species of plasmodium. Clinical features and complications. Life-cycle of plasmodium. Classification of antimalarial drugs. Individual drugs.

Q1

• What is the best choice of drug therapy?


Recommended